-+ 0.00%
-+ 0.00%
-+ 0.00%

Evolus Inc. Announces Landmark Study in JAMA Dermatology Highlighting Jeuveau® as Top Neurotoxin Performer

Reuters·07/31/2025 12:05:40

Please log in to view news